Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
J. A. Bell & M. H. Tarbit. (1992) Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry. Xenobiotica 22:7, pages 735-742.
Read now
Read now
Articles from other publishers (21)
Ehab Rasmy Bendas, Mamdouh R. Rezk & Kamal A. Badr. (2018) Drug Interchangeability of Generic and Brand Products of Fixed Dose Combination Tablets of Sofosbuvir and Ledipasvir (400/90 mg): Employment of Reference Scaled Average Bioequivalence Study on Healthy Egyptian Volunteers. Clinical Drug Investigation 38:5, pages 439-448.
Crossref
Crossref
Annalouise O'Connor, Veera Konda, Ralph L. Reed, J. Mark Christensen, Jan F. Stevens & Nikhat Contractor. (2018) Rice Protein Matrix Enhances Circulating Levels of Xanthohumol Following Acute Oral Intake of Spent Hops in Humans. Molecular Nutrition & Food Research 62:6, pages 1700692.
Crossref
Crossref
David E. Nix & Keith Gallicano. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
285
315
.
Roger K. Verbeeck & Joëlle Warlin. 2017. Bioequivalence Requirements in Various Global Jurisdictions. Bioequivalence Requirements in Various Global Jurisdictions
75
100
.
Sarfaraz K. Niazi. 2014. Handbook of Bioequivalence Testing. Handbook of Bioequivalence Testing
756
787
.
Rodrigo González‐Ramírez, Jessica González‐Bañuelos, María de la Salud Villa, Braulio Jiménez, Pilar García‐Roca, Leticia Cruz‐Antonio, Gilberto Castañeda‐Hernández & Mara Medeiros. (2014) Bioavailability of a generic of the immunosuppressive agent mycophenolate mofetil in pediatric patients. Pediatric Transplantation 18:6, pages 568-574.
Crossref
Crossref
Alwyn Pidgen. (1996) Bioequivalence and Generic Prescribing: An Industrial View. Journal of Pharmacy and Pharmacology 48:1, pages 11-16.
Crossref
Crossref
John W. Ahern & Kristen K. Pierce. (2011) Pharmacokinetics. Infectious Diseases in Clinical Practice 19:1, pages 16-24.
Crossref
Crossref
David E. Nix & Keith Gallicano. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
655
682
.
Sondra vanderVaart, Mary-Ellen Hogan & Thomas R. Einarson. (2010) . Clinical Therapeutics 32:2, pages 398.
Crossref
Crossref
Jovan Popović, Momir Mikov, Ana Sabo & Vida Jakovljević. (2009) Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers. European Journal of Drug Metabolism and Pharmacokinetics 34:2, pages 85-91.
Crossref
Crossref
David J. Greenblatt. (2008) Preparation of Scientific Reports on Pharmacokinetic Drug Interaction Studies. Journal of Clinical Psychopharmacology 28:4, pages 369-373.
Crossref
Crossref
Rabindra Patnaik. 2004. New Drug Development. New Drug Development
561
586
.
Robert M. Christley & Stuart W. J. Reid. (2003) No significant difference: use of statistical methods for testing equivalence in clinical veterinary literature. Journal of the American Veterinary Medical Association 222:4, pages 433-437.
Crossref
Crossref
Luciana Vismari, Maria Laura N Pires, Ana Amélia Benedito-Silva & Helena Maria Calil. (2002) Bioavailability of immediate and controlled release formulations of lithium carbonate. Revista Brasileira de Psiquiatria 24:2, pages 74-79.
Crossref
Crossref
Waranush Sorasuchart & James W. Ayres. (2001) Preliminary bioequivalence testing of two nicardipine HCl sustained-release formulations with in vitro/in vivo correlations. European Journal of Drug Metabolism and Pharmacokinetics 26:1-2, pages 1-7.
Crossref
Crossref
David Nix & Keith Gallicano. 2001. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
333
351
.
Pierre Schiavi, Roeline Jochemsen & David Guez. (2000) Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers. Fundamental & Clinical Pharmacology 14:2, pages 139-146.
Crossref
Crossref
H. Rosing, W. W. Ten Bokkel Huinink, R. van Gijn, R. F. M. Rombouts, A. Bult & J. H. Beijnen. (1999) Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane® and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC). European Journal of Drug Metabolism and Pharmacokinetics 24:1, pages 69-77.
Crossref
Crossref
John M. Kovarik, Edgar A. Mueller, Zoltan Kallay, Harold T. Smith, Arno E. Lison, Wolfgang Arns & Eckhard Renner. (2013) Concentration‐Guided Strategies in Drug Development: Experience with a Cyclosporine Analog in Transplantation. The Journal of Clinical Pharmacology 35:12, pages 1136-1143.
Crossref
Crossref
Claude Baudoin & John O'quigley. (2007) Symmetric Intervals and Confidence Intervals. Biometrical Journal 36:8, pages 927-934.
Crossref
Crossref